About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Current Medical Research and Opinion
›
Top Articles
Current Medical Research and Opinion
2.5
(top 7%)
Impact Factor
2.8
(top 7%)
extended IF
112
(top 3%)
H-Index
2.7K
authors
7K
papers
130.2K
citations
8.1K
citing journals
61.4K
citing authors
Most Cited Articles of Current Medical Research and Opinion
Title
Year
Citations
painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain
2006
1.3K
Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients
2008
636
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
2008
591
Cost-effectiveness analysis of micafungin versus caspofungin for treatment of systemic Candida infections in the UK
2009
532
The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population
2004
443
Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study
2002
424
Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US national survey
2014
416
The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making
2004
380
Good and poor adherence: optimal cut-point for adherence measures using administrative claims data
2009
361
Treatment-resistant schizophrenia--the role of clozapine
1997
325
Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study
2008
321
Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis
2005
319
The prevalence of anemia in patients with chronic kidney disease
2004
316
Diclofenac: an update on its mechanism of action and safety profile
2010
294
A New Therapeutic Target in Alzheimer's Disease Treatment: Attention to Butyrylcholinesterase
2001
289
Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide
2009
277
Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact
2011
273
The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3
2006
267
Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes
2009
256
Safety of botulinum toxin type A: a systematic review and meta-analysis
2004
232
Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
2013
223
Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial
2006
221
Population-based risk factors and resource utilization for HCC: US perspective
2010
217
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
2008
217
Real-world physician and patient behaviour across countries: Disease-Specific Programmes - a means to understand
2008
216
previous
2005
2006
2007
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.